(KRON) — The future of one biotech company on the Peninsula is drastically changing. Unity Biotechnology is laying off its entire workforce, the company announced Monday in a press release.

Controlling starch levels in algae could have biotechnology and sustainability benefits. ScienceDaily . Retrieved May 24, 2025 from www.sciencedaily.com / releases / 2025 / 04 / 250424121514.htm ...

For months, investors have feared that Health and Human Services Secretary Robert F. Kennedy Jr. and his Make America Healthy Again movement would derail biomedical innovation. His ousting of ...

DOHA: Qatar Free Zones Authority (QFZ) and BIOCAD– one of Russia’s leading biotechnology companies – yesterday signed a landmark Memorandum of Understanding, paving the way for the establishment of ...

The plans for using bio-feedstocks are particularly exciting. We have existing biotechnology skills and expertise that can play a significant role in the transition, while also being integrated ...

Emerging biotechnology is key for U.S. to remain dominant and secure future economic growth in a new era of global competition. WASHINGTON, April 8, 2025 /PRNewswire/ -- Today, the National Security ...

The comprehensive report from the bipartisan National Security Commission on Emerging Biotechnology (NSCEB) delivers a “sobering, even frightening,” conclusion: that China is quickly ascending to ...

The National Security Commission on Emerging Biotechnology was created by Congress in 2022 to explore how biotechnology advancements could shape the economy and national security. The group ...

China has captured production of portions of the global biotechnology supply chain to accomplish President Xi Jinping’s goal to “develop effective deterrent against attempts by other countries ...

Dec. 19, 2024 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it will be added to the Nasdaq Biotechnology Index (Nasdaq ...

New Delhi: Biotechnology is set to lead India's next ... particularly for biologics and innovative therapies. With the introduction of an online system, approval times have been slashed from ...

Sept 26 (Reuters) - AstraZeneca will pay $18 million to biotechnology firm Immunai Inc to use the New York-based firm's AI model of the immune system to make certain cancer drug trials more ...